From: Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study
 | pt1 | pt2 | pt3 | pt4 | pt5 | pt6 | pt7 | pt8 | pt9 |
---|---|---|---|---|---|---|---|---|---|
Type of GD | MN | MN | FSGS | FSGS | IgAN | IgAN | IgAN | MCNS | MN |
Age at GD diagnosis (years) | 51.9 | 50.6 | 56.4 | 46.3 | 52.5 | 22.2 | 25.2 | 28.7 | 44 |
Proteinuria level (g/d) | 1.8 | 4.3 | 1.7 | 6.6 | 1 | 1.3 | 1 | 3 | 7 |
GFR (ml/min/1.73Â m2) | 35 | 69 | 56 | 60 | 97 | 96 | 81 | 92 | 89 |
Serum Albumin (g/L) | 43 | 31.6 | 38 | 27 | 17 | 35 | 38 | 29 | 16 |
GTIN (+ present -absent) | + | - | + | - | + | + | - | + | + |
Affected organs | Lymph nodes Erythema Nodosum | Spleen Lymph nodes parotitis | Lung Skin | Lung Lymp nodes | Lung Lymph nodes Liver Spleen Bone marrow Salivary glands | Lung Lymph nodes Liver Spleen parotidis | Lymph nodes | Lymph nodes Skin epididymitis | Lymph nodes Salivary glands |
Radiographic classification (stage) | 1 | 0 | 2 | 2 | 3 | 1 | 1 | 1 | 1 |
Steroid treatment | yes | no | yes | yes | yes | yes | yes | yes | yes |
Remission of GD with steroids | CR | no | CR | no | PR | CR | CR | PR | PR |
Remission of sarcoidosis with steroids | no | no | no | no | yes | no | yes | yes | yes |
Other immunosuppressive treatment (date of introduction) | Plaquenil (M7) | Â | Plaquenil (M19) | Aza (M13) | Â | Aza (M18) | Â | MMF (M12) | Â |
Duration of follow-up (years) | 9 | 0.6 | 2.7 | 5 | 0.6 | 3.3 | 10.8 | 2 | 0.6 |
GFR at the end of follow-up (mL/min/1.73Â m2) | 56.8 | 67 | died | dialysis | 86.6 | 120.4 | 78.1 | 80 | 72 |